학술논문
MA 02.09 A Ph I/II Study of BGB324, a Selective AXL Inhibitor as Monotherapy and in Combination with Erlotinib in Advanced NSCLC
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1805-S1805
Subject
Language
ISSN
1556-0864